ASX:COH Cochlear (COH) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Cochlear Stock (ASX:COH) 30 days 90 days 365 days Advanced Chart Get Cochlear alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume201,277 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend Yield1.44%Price TargetN/AConsensus RatingN/A Company OverviewCochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. The company was founded in 1981 and is headquartered in Sydney, Australia.Read More… Receive COH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cochlear and its competitors with MarketBeat's FREE daily newsletter. Email Address COH Stock News HeadlinesGoldman Sachs sets Cochlear stock target, rating NeutralJanuary 16, 2025 | msn.comCochlear Limited Announces Continued Share Buy-BackNovember 19, 2024 | markets.businessinsider.comTrump’s Inauguration Shocker: “Move Your Cash Now”Just in the first week after Trump's win, many stocks jumped by double and even triple digits. But now he's issuing this NEW warning about Trump's inauguration.January 22, 2025 | InvestorPlace (Ad)Cochlear Limited Director Boosts Securities HoldingsNovember 19, 2024 | markets.businessinsider.comCochlear Limited Announces New Equity IssuanceNovember 19, 2024 | markets.businessinsider.comCochlear Limited Updates on Share Buy-Back ProgramNovember 14, 2024 | markets.businessinsider.comCochlear Limited Updates on Share Buy-back ProgressNovember 13, 2024 | markets.businessinsider.comCochlear Limited Announces Director’s Stock TransactionsNovember 4, 2024 | markets.businessinsider.comSee More Headlines COH Stock Analysis - Frequently Asked Questions How were Cochlear's earnings last quarter? Cochlear Limited (ASX:COH) announced its earnings results on Tuesday, February, 19th. The company reported $2.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.19 by $0.04. Cochlear had a trailing twelve-month return on equity of 19.88% and a net margin of 15.96%. What other stocks do shareholders of Cochlear own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cochlear investors own include CSL (CSL), ResMed (RMD), NIB (NHF), Accent Group (AX1), Corporate Travel Management (CTD), Mineral Resources (MIN) and Technology One (TNE). Company Calendar Last Earnings2/19/2019Today1/22/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:COH CUSIPN/A CIKN/A Webwww.cochlear.com Phone+61-2-94286555FaxN/AEmployees4,996Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)A$5.43 Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth3.87Net Income$356.80 million Net Margins15.96% Pretax MarginN/A Return on Equity19.88% Return on Assets11.99% Debt Debt-to-Equity Ratio13.24 Current Ratio2.30 Quick Ratio1.93 Sales & Book Value Annual Sales$2.24 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow123.45 Book ValueA$28.10 per share Price / BookN/AMiscellaneous Outstanding Shares65,500,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.47 Unlock the Potential in Options TradingOptions trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.Get This Free Report This page (ASX:COH) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cochlear Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cochlear With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
